— Know what they know.
Not Investment Advice

GKOS NYSE

Glaukos Corporation
1W: -2.1% 1M: +14.4% 3M: +15.7% YTD: +25.6% 1Y: +42.7% 3Y: +132.2% 5Y: +86.1%
$120.23
-18.80 (-13.52%)
 
Weekly Expected Move ±12.1%
$109 $127 $144 $161 $179
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 62 · $7.1B mcap · 56M float · 1.32% daily turnover · Short 57% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$507M +32.3% ▲
5Y CAGR: +17.7%
Gross Profit
$283M -2.3% ▼
5Y CAGR: +16.2%
Operating Income
-$200M -63.1% ▼
Net Income
-$188M -28.2% ▼
EPS (Diluted)
$-3.28 -18.4% ▼
EBITDA
-$150M -57.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$294M$283M$315M$383M$507M
YoY Growth+30.7%-3.8%+11.3%+21.9%+32.3%
Cost of Revenue$67M$69M$76M$94M$225M
Gross Profit$227M$214M$239M$289M$283M
Gross Margin77.3%75.6%76.0%75.5%55.7%
R&D Expenses$101M$123M$139M$136M$151M
SG&A Expenses$179M$193M$224M$263M$332M
Operating Expenses$260M$296M$368M$412M$482M
Operating Income-$33M-$82M-$129M-$122M-$200M
Operating Margin-11.2%-29.1%-40.9%-31.9%-39.3%
Interest Expense$13M$14M$14M$10M$5M
Income Before Tax-$49M-$98M-$134M-$146M-$193M
Tax Expense$326K$766K$934K$771K-$5M
Net Income-$50M-$99M-$135M-$146M-$188M
Net Margin-16.9%-35.1%-42.8%-38.2%-37.0%
EPS (Diluted)$-1.07$-2.09$-2.78$-2.77$-3.28
EBITDA-$1M-$49M-$82M-$96M-$150M
Shares Outstanding46M47M48M53M57M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms